Assessment of Coagulopathy Risk in Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study in Thumbay Hospital, UAE

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Alobeidli F.A.; Abdalhadi I.M.M.; Osma H.A.; Yousif T.Y.E.; Abdelmola A.; Yousif I.O.M.; Saboor M.; Sukar K.A.O.; Abdmomen N.K.; Alfeel A.H.

Journal: International Journal of Biomedicine

Publisher: International Medical Research and Development Corporation

Publication Date: 5 December 2024

Volume / Issue: Volume 14 / Issue 4

Pages: 563–568

ISSN: 21580510

DOI: 10.21103/Article14(4)_OA4

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Bronze Open Access


Authors and Affiliations

Alobeidli F.A., College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates; Abdalhadi I.M.M., College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates; Osma H.A., Faculty of Medical and Health Sciences, Liwa College, Abu Dhabi, United Arab Emirates; Yousif T.Y.E., Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia; Abdelmola A., Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia; Yousif I.O.M., College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates; Saboor M., College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Sukar K.A.O., Collage of Heath Sciences, Gulf Medical University, Ajman, United Arab Emirates, Faculty of Medicine, University of Bakht Alruda, Ed Dueim, Sudan; Abdmomen N.K., Faculty of Medicine, Gulf Medical University, Ajman, United Arab Emirates, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research and Higher Education, Giza Governorate, Egypt; Alfeel A.H., College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates


Abstract

Background: Type 2 diabetes mellitus(T2DM) is associated with coagulation abnormalities and a higher risk for blood clots due to changes in the clotting factors and platelet function. This study aimed to assess blood clotting parameters in T2DM patients within a single research center in the UAE. Methods and Results: This retrospective, cross-sectional study was conducted on 158 patients (112 men and 46 women) diagnosed with T2DM in Thumbay Hospital, Ajman, UAE. Blood samples were properly labeled and used for screening tests. The HbA1c and platelet tests were performed using the Beckman Coulter DxC 700 and DxH 900 analyzers. Coagulation profile tests, including D-dimer, activated partial thromboplastin time (APTT), and prothrombin time (PT), were performed using an ACL TOP 300 CTS analyzer. All patients were divided into two groups. Group 1 included 68 patients with controlled diabetes (cT2DM), and Group 2 included 90 patients with uncontrolled diabetes (uT2DM). The assessment of the blood clotting parameters showed a lower level of INR in the uT2DM group than in the cT2DM group (1.06±0.10 and 1.53±1.13, respectively, P=0.0001). Platelet count, PT, APTT, and D-dimer levels did not differ significantly between the two groups. Men had a higher HbA1c than women (7.30±2.07% and 6.52±2.02%, respectively, P=0.0318), indicating poor diabetes control. Higher HbA1c in men was accompanied with a higher D-dimer level (409.1±44.4 ng/mL for men and 388.7±42.1 ng/mL for women, P=0.0086) and a lower level of INR (1.09±0.10 and 1.73±1.13, respectively, P=0.0001). Platelet count, PT and APTT levels did not differ significantly between male and female patients. Evaluation of the studied parameters, considering age groups, showed increased HbA1c with age (P=0.0018), indicating an increase in poor diabetes control. This was accompanied by a significant increase in the D-dimer levels in the age group above 45 (P=0.0000).The levels of other indicators did not differ significantly depending on the age group. Conclusion: Patients with T2DM have a cumulative thrombotic risk. The prothrombotic state in T2DM is primarily mediated by hyperglycemia and insulin resistance. Good glycemic control (HbA1c<7.0%) in T2DM has reduced the risk of developing thrombotic complications. © 2024, International Medical Research and Development Corporation. All rights reserved.


Keywords

diabetes control; platelet count; thrombotic risk; type 2 diabetes mellitus


Citation Information

Scopus Citations: 0


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]